0000000000454397

AUTHOR

Pooja Verma

showing 3 related works from this author

Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction …

2009

Dibutyltin(IV) complexes of composition Bu2Sn (LH)2, where LH is a carboxylate residue derived from 2-[(E)- (5-tert-butyl-2- hydroxyphenyl)diazenyl]benzoate (L1H) with water molecule (1), 4-[(E)-(5-tert-butyl-2-hydroxyphenyl) diazenyl]benzoate (L2H) (2) and 4-[(E)-(4-hydroxy-5- methylphenyl)diazenyl]benzoate (L3H) (3), were synthesized and characterized by spectroscopic (1H, 13C and 119Sn NMR, IR, 119Sn Mössbauer) techniques. A full characterization was accomplished from the crystal structure of complex 1. The molecular structures and geometries of the complexes (1a i.e. 1 without water molecule and 3) were fully optimized using the quantum mechanical method (PM6). Complexes 1 and 3 were fo…

Models MolecularStereochemistryMolecular ConformationCrystallography X-RayLigandsThymidylate synthaseAnti-cancer drugchemistry.chemical_compoundCell Line TumorRibonucleotide ReductasesOrganotin CompoundsMoleculeHumansPharmacology (medical)CarboxylateArylazobenzoateSpectroscopyPharmacologychemistry.chemical_classificationBinding SitesbiologyCell DeathTopoisomeraseHydrogen BondingThymidylate SynthaseIn vitroEnzymesRibonucleotide reductaseEnzymeDNA Topoisomerases Type IIOncologychemistrySettore CHIM/03 - Chimica Generale E InorganicaDocking (molecular)Docking studieDibutyltin(IV) compoundbiology.proteinQuantum TheoryDrug Screening Assays AntitumorCell lineInvestigational new drugs
researchProduct

Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: Synthesis, structural characterization, in vitro cytotoxicity and study of…

2009

Summary: Triphenyltin(IV) complexes of composition [Ph3SnL 1H]n (1) and [Ph3SnL2H]n (2) (where L1H=2-[(E)-2-(3-formyl-4-hydroxyphenyl)-1-diazenyl] benzoate and L2H = 2-[(E)-2-(4-Hydroxy-5-methylphenyl)-1-diazenyl] benzoate) were synthesized and characterized by spectroscopic (1H, 13C and 119Sn NMR, IR, 119Sn Mössbauer) techniques in combination with elemental analysis. The molecular structures and geometries of the complexes (1 and 2) were fully optimized using the quantum mechanical method (PM3). Complexes (1 and 2) were found to exhibit stronger cytotoxic activity in vitro across a panel of human tumour cell lines viz., A498, EVSA-T, H226, IGROV, M19 MEL, MCF-7 and WIDR. The test compound…

Models MolecularMagnetic Resonance SpectroscopySpectrophotometry InfraredStereochemistryTriphenyltin(IV) 2-[(E)-2-(4-Hydroxy-5-methylphenyl)-1-diazenyl]benzoateAntineoplastic AgentsCrystallography X-RayThymidylate synthaseAnti-cancer drugTriphenyltin(IV) benzoateCell Line TumorRibonucleotide ReductasesOrganotin CompoundsHumansPharmacology (medical)Pharmacologychemistry.chemical_classificationBinding SitesbiologyCell DeathChemistryTopoisomeraseThymidylate SynthaseIn vitroBenzoatesRibonucleotide reductaseEnzymeOncologyDocking (molecular)Cell cultureSettore CHIM/03 - Chimica Generale E InorganicaDocking studiebiology.proteinQuantum TheoryThermodynamicsTriphenyltin(IV) 2-[(E)-2-(3-formyl-4-hydroxyphenyl)-1-diazenyl]benzoateDrug Screening Assays AntitumorCell line
researchProduct

Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl] benzoates endowed with an improved cytotoxic profile: Synth…

2010

A series of tributyltin(IV) complexes based on 2/4-[(E)-2-(aryl)-1-diazenyl]benzoate ligands was synthesized, wherein the position of the carboxylate and aryl substituents (methyl, tert-butyl and hydroxyl) varies. The complexes, Bu(3)SnL(1-4)H (1-4), have been structurally characterized by elemental analysis and IR, NMR ((1)H, (13)C, and (119)Sn) and (119)Sn Mossbauer spectroscopy. All have a tetrahedral geometry in solution and a trigonal bipyramidal geometry in the solid-state, except for Bu(3)SnL(4)H (4) that was ascertained to have tetrahedral coordination by X-ray crystallography. Cytotoxicity studies were carried out on human tumor cell lines A498 (renal cancer), EVSA-T (mammary cance…

Models MolecularQuantitative structure–activity relationshipMagnetic Resonance SpectroscopyStereochemistryCell SurvivalANTITUMOR-ACTIVITYHydrophobicityQuantitative Structure-Activity RelationshipAntineoplastic AgentsCrystallography X-RayBiochemistryBenzoatesVALIDATIONInorganic Chemistrychemistry.chemical_compoundAnti-cancer drugCell Line TumorOrganotin CompoundsTRIORGANOTIN(IV) COMPLEXESHumansCRYSTAL-STRUCTURESCarboxylateOPTIMIZATIONArylazobenzoateSpectroscopyX-ray crystallographyMolecular StructureQSARArylTetrahedral molecular geometryNuclear magnetic resonance spectroscopyBenzoatesTributyltin(IV) compoundTrigonal bipyramidal molecular geometryMOSQUITO LARVAEchemistryCELL-DEATHDocking (molecular)Settore CHIM/03 - Chimica Generale E InorganicaDocking studies RIBONUCLEOTIDE REDUCTASE INHIBITORSEMIEMPIRICAL METHODSTrialkyltin CompoundsCell lineAEDES-AEGYPTI
researchProduct